Skip to main content
Log in

Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: A randomised crossover study

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Twelve patients with essential hypertension on no other drug treatment were entered into a randomised crossover study of 5, 10 and 20 mg capsules of nifedipine given 3 times a day and 20 mg tablets given twice a day. Each dose was given for 2 weeks in a random order. All forms of nifedipine were effective in lowering blood pressure.

However, 5 mg capsules were less effective than the 10 and 20 mg capsules or 20 mg tablets. There was little to choose between the latter. All doses of nifedipine were more effective 1 and 3 h after the dose compared to subsequent times afterwards. Indeed, as time elapsed after the last dose up to 12 h, there was a gradual increase in blood pressure. However, even at 12 h the 10, 20 mg capsules and 20 mg tablets were still causing an approximate 10% reduction in blood pressure.

Nifedipine tablets are as effective as capsules though they might be longer acting, particurarly around 6 h after the last dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K, Takikawa K (1978) Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96: 218–226

    Google Scholar 

  • Bailey S, Dobbs RJ, Robinson BF (1982) Nifedipine in the treatment of hypertension: Report of a double blind controlled trial. Br J Clin Pharmacol 14: 509–512

    Google Scholar 

  • Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P (1983) Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 24: 145–150

    Google Scholar 

  • Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA (1985) Sodium restriction lowers high blood pressure through a decreased response of the renin system. Direct evidence using saralasin. J Hypertens 3: 243–247

    Google Scholar 

  • Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F, Moruzzi P (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532

    Google Scholar 

  • Hallin L, Andren L, Hansson L (1983) Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 5: 1083–1085

    Google Scholar 

  • Hornung RS, Gould BA, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intra-arterial recording. Am J Cardiol 51: 1323–1327

    Google Scholar 

  • Jakobsen P, Lederballe Pedersen O, Mikkelsen E (1979) Determination of nifedipine and one of its metabolites using electroncapture detection. J Chromatogr 162: 81–87

    Google Scholar 

  • Landmark K (1985) Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets. J Cardiovasc Pharmacol 7: 12–17

    Google Scholar 

  • Lederballe Pedersen O, Mikkelsen E (1978) Acute and chronic effects of nifedipine in arterial hypertension. Eur J Clin Pharmacol 14: 375–381

    Google Scholar 

  • MacGregor GA, Markandu ND, Rotellar C, Smith SJ, Sagnella GA (1983) The acute response to nifedipine is related to pretreatment blood pressure. Postgrad Med J 59 [Suppl 2]: 91–94

    Google Scholar 

  • Marone C, Luisoli S, Bomio F, Beretta Piccoli C, Bianchetti MG, Weidmann P (1984) Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic. J Hypertens 2 [Suppl 3]: 449–452

    Google Scholar 

  • Midtbo K, Hals O, van der Meer J (1982) Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol 4 [Suppl 3]: 363–368

    Google Scholar 

  • Ochs HR, Ramsch KD, Verburg-Ochs B, Greenblatt DJ, Gerloff J (1984) Nifedipine: Kinetics and dynamics after single oral doses. Klin Wochenschr 62: 427–429

    Google Scholar 

  • Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD (1979) Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59: 1056–1062

    Google Scholar 

  • Raemsch KD, Sommer J (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension 5 [Suppl 2]: 18–24

    Google Scholar 

  • Taburet AM, Singlas E, Colin JN, Banzet O, Thibonnier M, Corvol P (1983) Pharmacokinetic studies of nifedipine tablet — correlation with antihypertensive effects. Hypertension 5 [Suppl 2]: 29–33

    Google Scholar 

  • Thibonnier M, Bonnet F, Corvol P (1980) Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension. Eur J Clin Pharmacol 17: 161–164

    Google Scholar 

  • Tucker FA, Minty PSB, MacGregor GA (1985) Study of nifedipine photodecomposition in plasma and whole blood using capillary gas liquid chromatography. J Chromatogr 342: 193–198

    Google Scholar 

  • Zar JH (1984) Biostatistical analysis (2nd edn). Prentice-Hall, Englewood Cliffs, NJ 07632

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappuccio, F.P., Markandu, N.D., Tucker, F.A. et al. Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: A randomised crossover study. Eur J Clin Pharmacol 30, 723–725 (1986). https://doi.org/10.1007/BF00608223

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00608223

Key words

Navigation